001 | 478837 | ||
005 | 20201223144436.0 | ||
024 | 7 | _ | |a 10.1007/s00213-014-3794-9 |2 doi |
024 | 7 | _ | |a WOS:000352786900010 |2 WOS |
024 | 7 | _ | |a pmid:25373869 |2 pmid |
024 | 7 | _ | |a PREV201500419829 |2 BIOSIS |
024 | 7 | _ | |a 0033-3158 |2 ISSN |
024 | 7 | _ | |a 1432-2072 |2 ISSN |
024 | 7 | _ | |a SCOPUS:2-s2.0-84939938916 |2 SCOPUS |
037 | _ | _ | |a RWTH-2015-02733 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |0 P:(DE-82)076647 |a Veselinovic, Tanja |b 0 |e Corresponding author |
245 | _ | _ | |a Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers |h online, print |
260 | _ | _ | |a Berlin |b Springer |c 2015 |
336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
336 | 7 | _ | |2 DRIVER |a article |
336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |
336 | 7 | _ | |2 BibTeX |a ARTICLE |
336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
588 | _ | _ | |a Dataset connected to CrossRef |
591 | _ | _ | |a Germany |
700 | 1 | _ | |a Vernaleken, Ingo |0 P:(DE-82)014516 |b 1 |
700 | 1 | _ | |a Janouschek, Hildegard |0 P:(DE-82)019279 |b 2 |
700 | 1 | _ | |a Kellermann, Thilo |0 P:(DE-82)IDM03646 |b 3 |u rwth |
700 | 1 | _ | |a Paulzen, Michael |0 P:(DE-82)028941 |b 4 |
700 | 1 | _ | |a Cumming, Paul |0 P:(DE-82)052424 |b 5 |
700 | 1 | _ | |a Gründer, Gerhard |0 P:(DE-82)012827 |b 6 |
773 | _ | _ | |0 PERI:(DE-600)2066933-1 |a 10.1007/s00213-014-3794-9 |n 9 |p 1607-1617 |t Psychopharmacology |v 232 |x 1432-2072 |y 2015 |
909 | C | O | |o oai:publications.rwth-aachen.de:478837 |p VDB |
914 | 1 | _ | |y 2015 |
915 | 1 | _ | |0 StatID:(DE-HGF)0031 |2 HGFVOC |a Peer reviewed article |x 0 |
915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b PSYCHOPHARMACOLOGY : 2014 |
915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
915 | _ | _ | |0 StatID:(DE-HGF)0110 |2 StatID |a WoS |b Science Citation Index |
915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |
915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
915 | _ | _ | |0 StatID:(DE-HGF)9900 |2 StatID |a IF < 5 |
915 | _ | _ | |0 StatID:(DE-HGF)0420 |2 StatID |a Nationallizenz |
915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b PSYCHOPHARMACOLOGY : 2015 |
915 | _ | _ | |0 StatID:(DE-HGF)0600 |2 StatID |a DBCoverage |b Ebsco Academic Search |
920 | 1 | _ | |0 I:(DE-82)535500-2_20140620 |k 535500-2 |l Lehrstuhl für Psychiatrie, Psychotherapie und Psychosomatik |x 0 |
920 | 1 | _ | |0 I:(DE-82)535500-4_20140620 |k 535500-4 |l Lehr- und Forschungsgebiet Experimentelle Psychopathologie |x 1 |
920 | 1 | _ | |0 I:(DE-82)535500-3_20140620 |k 535500-3 |l Lehr- und Forschungsgebiet Experimentelle Neuropsychiatrie |x 2 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-82)535500-2_20140620 |
980 | _ | _ | |a I:(DE-82)535500-4_20140620 |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-82)535500-3_20140620 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|